Filing Flows › DataMeds AI (MEDS) › Q1 2026 › vs Q4 2025
DataMeds AI (MEDS) Q1 2026 vs Q4 2025 (quarter over quarter)
DataMeds AI's revenue fell $111K (-7%) from $1.7M in Q4 2025 to $1.6M in Q1 2026. The biggest changes: Product −$788K (-78%); Pharmacy Retail Sales +$633K (+126%); Third Party Logistics Services +$44K (+28%).
DataMeds AI, Q1 2026: revenue $1.6M (-86% year over year), operating margin -385.7%, net loss $7.7M, operating cash flow −$3.4M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Pharmacy Retail Sales | $1.1M | $501K | $633K | +126% |
| Product | $226K | $1.0M | −$788K | -78% |
| Third Party Logistics Services | $199K | $155K | $44K | +28% |
| Revenue | $1.6M | $1.7M | −$111K | -7% |
| Net loss | $7.7M | $27.9M | −$20.1M | -72% |
| Costs & expenses | $9.3M | $29.5M | −$20.2M | -68% |
| Operating costs | $7.6M | $27.0M | −$19.4M | -72% |
| Interest & other, net | $1.7M | $2.5M | −$774K | -31% |
| Cost of revenue | $1.4M | $9.5M | −$8.1M | -85% |
| Sales & marketing | $960K | $12K | $948K | 79× |
| General & admin | $4.9M | $4.1M | $742K | +18% |
| Other operating costs | $357K | $13.4M | −$13.0M | -97% |
| Operating cash sources | $7.7M | $27.9M | −$20.1M | -72% |
| Depreciation & amortization | $357K | $803K | −$446K | -56% |
| Share-based compensation | $1.4M | $356K | $1.0M | +282% |
| Working capital & other | $2.6M | $20.4M | −$17.8M | -87% |
| Cash used in operations | $3.4M | $6.3M | −$2.9M | -46% |
| Net loss absorbed | $7.7M | $27.9M | −$20.1M | -72% |
Questions
How much did DataMeds AI's revenue grow quarter over quarter in Q1 2026?
DataMeds AI's revenue fell $111K (-7%) from $1.7M in Q4 2025 to $1.6M in Q1 2026.
What drove DataMeds AI's revenue change in Q1 2026?
Product −$788K (-78%); Pharmacy Retail Sales +$633K (+126%); Third Party Logistics Services +$44K (+28%).